ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $220,870 | -12.7% | 4,788 | -21.8% | 0.01% | +55.6% |
| Q3 2022 | $253,000 | +9.1% | 6,119 | +121.8% | 0.01% | +50.0% |
| Q4 2021 | $232,000 | -37.1% | 2,759 | -28.7% | 0.01% | -45.5% |
| Q2 2021 | $369,000 | +63.3% | 3,869 | +94.9% | 0.01% | +83.3% |
| Q1 2021 | $226,000 | +247.7% | 1,985 | +150.0% | 0.01% | +100.0% |
| Q3 2020 | $65,000 | -90.0% | 794 | -90.5% | 0.00% | -91.7% |
| Q2 2020 | $651,000 | +425.0% | 8,322 | +197.2% | 0.04% | +350.0% |
| Q1 2020 | $124,000 | +1277.8% | 2,800 | +2070.5% | 0.01% | +700.0% |
| Q1 2019 | $9,000 | -98.2% | 129 | -98.4% | 0.00% | -97.9% |
| Q2 2017 | $497,000 | +163.0% | 8,000 | +167.3% | 0.05% | +80.8% |
| Q1 2016 | $189,000 | – | 2,993 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |